Companion Biomarkers in Drug Development ----Aarkstore Enterprise Digg this page for free send this page to a friend Add to your del.icio.us account

The term “companion biomarker” means that a particular diagnostic test is specifically linked to a therapeutic drug either in drug development or in the clinic. Biomarkers of disease have long played an important role in diagnostic medicine as evidenced by the intense use of specific clinical laboratory tests in the diagnosis of disease. Biomarkers can be used in five very distinct ways in drug development: 1) companion biomarkers can be correlated with biological events during drug development in order to validate drug targets or to predict drug response; 2) biomarkers can be used as companion diagnostics in drug development to characterize patient populations in order to better understand the extent to which new drugs reach intended therapeutic targets can alter proposed therapeutic pathways and achieve successful clinical outcomes; 3) biomarkers can be used to stratify patient populations for drug response in primary prevention or disease-modification studies, particularly in specific clinical areas such as neuron degeneration and cancer; 4) clinically useful biomarkers are becoming increasingly useful to make proper therapeutic decisions regarding candidate drugs; and 5) clinically useful biomarkers are becoming increasingly required by the FDA and other outside authorities to make proper regulatory decisions regarding candidate drugs. This report describes new biomarker technology platforms developed for the analyses of drug targets that are connected to the effectiveness of therapeutic agents in a clinical setting. The emphasis is on those companies that are actively developing and marketing new companion diagnostic tests for performing biomarker tests during drug development, as opposed to the more routine and clinically accepted companion markers that are manufactured and marketed by large diagnostic companies for routine clinical use.

For more information please contact :

http://www.aarkstore.com/ reports/ Companion-Biomarkers-in-Drug-Development-13521.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise
Contact: Neel
Email:
URL: http://www.aarkstore.com
User comments, Ratings and Reviews
News Reviews and Ratings
Be the first person to review this news article. By reviewing the news article you are automatically sent to our Online Sweepstakes and any questions on journal postings and more info from here
News Album Team,  Thursday, May 23, 2013 10:57:47 AM
Note: To write new journal then start here. The below is only to re-write the existing journal
Write your own Review on This News:

Required valid email. Confirmation sent here.
Not Much. 1 2 3 4 5 So Much......!

Human Verification Code     
Read more! [Bookmark & read later / Comment this story ]
Share this article:

You can Digg this article: Digg this page for free
Send Page to Friend(s):send this page to a friend
Bookmark with del.icio.us:Add to your del.icio.us account

Cast My Opinion

  

Contact Author: Click here to eMail
Neel from 59.184.176.xxx

Article Taged as : companion, biomarkers, drug, development, ----aarkstore, enterprise, www.aarkstore.com, companion, biomarkers, drug, development, ----aarkstore, enterprise,

Article Statistics

Article Viewed 2660 times.
Positive attitude 1 votes [0%]
Negetive attitude 1 votes [0%]

News Article Source & Groups

You can find this article under group. And brought to you by Channel ,
The XMl Feed Type and collected data bytes sized news and still counting.
Feed Server name is and Code Page (Not Defined/Un Known)

: : Companion Biomarkers in Drug Development ----Aarkstore Enterprise
Date Listed : Wednesday, March 17, 2010
Source : ,

Related Stories
Home | Topics | Tell a Friend | Webmaster | Events | Subscribe | Link us | Submit News | My List